ACTBP6, identified as Actin Beta Pseudogene 6, is a non-functional genomic element belonging to the beta-actin gene family, which encodes a critical cytoskeletal protein essential for maintaining cell morphology, facilitating motility, enabling cell division, and mediating intracellular signal transduction. Although ACTBP6 exhibits high sequence homology with the functional beta-actin gene (ACTB), it has lost its protein-coding capacity due to disruptive mutations, such as insertions, deletions, or premature stop codons, that compromise the integrity of its open reading frame. Despite its lack of direct protein product, ACTBP6 may exert indirect regulatory effects on ACTB expression through mechanisms such as the "sponge effect," where its transcripts sequester microRNAs that would otherwise inhibit ACTB, potentially leading to actin overexpression and subsequent disruption of cytoskeletal homeostasis. While no direct causal link between specific ACTBP6 mutations and distinct clinical phenotypes has been established, dysregulation of the broader beta-actin family is implicated in severe pathological conditions, including cancer metastasis, cardiovascular disorders, and neurodegenerative diseases like Alzheimer’s disease. Consequently, abnormal expression levels of ACTBP6—whether through overexpression that perturbs actin dynamics and cell proliferation, or underexpression that diminishes regulatory buffering—may contribute to cellular dysfunction, highlighting the emerging, albeit still early-stage, understanding of pseudogenes as potential modulators of gene expression and cellular mechanics in eukaryotic systems.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]